Objective: The purpose of this study was to evaluate the clinical efficacy of subcooling combined with minimally invasive hematoma removal on the protection of neurological function in patients with hypertensive intracerebral hemorrhage through Meta-analysis. Methods: Computer searches was conducted in multiple databases including PubMed, Embase, Cochrane Central Register of Controlled Trials, Web of Science, China Knowledge Network(CNKI), China Biomedical Literature Database(CBM), Wanfang Database(WANFANG), and China Science and Technology Periodical databases(VIP). Based on the established database of hypertensive intracerebral hemorrhage patients treated with subcooling therapy after minimally invasive hematoma removal, the literatures related to its randomized controlled trials(RCTs) were screened and assessed for quality. Meta-analysis was performed with the Revman 5.3 software. Results: There were a total of 12 papers included in this study, all of which were single-center RCT studies that involved 1 093 patients. Compared to the conventional treatment group(control group), patients with hypertensive intracerebral hemorrhage after minimally invasive hematoma removal combined with subcooling therapy(hereinafter referred to as the combined treatment group), 9 papers showed that the combined treatment had a significant impact on decreasing the National Institute of Health stroke scale(NIHSS) scores (MD=-4.29, 95%CI-5.27--3.23, P<0.001); 3 papers showed that the combined treatment could effectively improve the Fugl-Meyer assessment scale(FMA) scores(MD=27.66, 95%CI 18.45-36.86,P<0.001); 3 papers showed that the combined treatment was effective in improving the Glasgow coma scale(GCS) scores(MD=34.79, 95%CI 33.19-36.39, P< 0.001); and 8 papers showed that the combined treatment was effective in improving the Barthel Index(BI)(MD=8.72, 95%CI 6.89-10.54, P<0.001); all of the included literature showed that the combination therapy could enhance the efficiency(RR=1.28, 95%CI 1.20-1.36, P<0.001); while 5 papers showed that the combination therapy did not have any significant reduction in the incidence of adverse effects(MD=0.52, 95%CI 0.32-0.85). Conclusion: The combination of subcooling and minimally invasive hematoma removal has the effect of promoting the recovery of neurological function in patients with hypertensive intracerebral hemorrhage. |
[1] 游潮,刘鸣,于学忠,等.高血压性脑出血中国多学科诊治指南[J].中国急救医学,2020,40(8):689-702.
[2] TANG Y,YIN F,FU D,et al.Efficacy and safety of minimal invasive surgery treatment in hypertensive intracerebral hemorrhage:a systematic review and Meta-analysis[J].BMC Neurol,2018,18(1):136.
[3] MOULD W A,CARHUAPOMA J R,MUSCHELLI J,et al.Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema[J].Stroke,2013,44(3):627-634.
[4] CARHUAPOMA J R,BARRETT R J,KEYL P M et al.Stereotactic aspiration-thrombolysis of intracerebral hemorrhage and its impact on perihematoma brain edema[J].Neurocrit Care,2008,8(3):322-329.
[5] SCAGGIANTE J,ZHANG X,MOCCO J,et al.Minimally invasive surgery for intracerebral hemorrhage[J].Stroke,2018,49(11):2612-2620.
[6] BARNES B,HANLEY D F,CARHUAPOMA J R.Minimally invasive surgery for intracerebral haemorrhage[J].Curr Opin Crit Care,2014,20(2):148-152.
[7] 中国研究型医院学会神经再生与修复专业委员会心脏重症脑保护学组,中国研究型医院学会神经再生与修复专业委员会神经重症护理与康复学组.亚低温脑保护中国专家共识[J].中华危重病急救医学,2020,32(4):385-391.
[8] LIU S,GENG X,FORREIDER B,et al.Enhanced beneficial effects of mild hypothermia by phenothiazine drugs in stroke therapy[J].Neurol Res,2015,37(5):454-460.
[9] 曾晓俊.亚低温血肿微创清除术治疗高血压脑出血的效果[J].中国继续医学教育,2020,12(19):123-125.
[10] 陈秋香.颅内血肿微创清除术联合亚低温治疗重症高血压脑出血的效果[J].心血管病防治知识,2022,12(23):51-54.
[11] 杜柏,孙吉庆.颅内血肿微创清除术联合亚低温治疗重症高血压脑出血的临床观察[J].中国疗养医学,2018,27(3):266-267.
[12] 杜立清.颅内血肿微创清除术联合亚低温治疗重症高血压脑出血的临床分析[J].医药卫生,2022(8):55-58.
[13] 季学成,陈水钰,周晓丽,等.颅内血肿微创清除术联合亚低温治疗重症高血压脑出血的临床疗效分析[J].中外医疗,2017,36(24):24-26.
[14] 李磊,丁建军,遇旭东,等.颅内血肿微创清除术联合亚低温治疗重症高血压脑出血的临床疗效和安全性分析[J].中外医疗,2017,36(6):82-84.
[15] 舒内华.颅内血肿微创清除术联合亚低温治疗重症高血压脑出血患者的临床疗效[J].实用临床医药杂志,2018,22(15):23-25,32.
[16] 王桂权.颅内血肿微创清除术联合亚低温治疗重症高血压脑出血临床效果观察[J].中国现代药物应用,2019,13(5):18-19.
[17] 郑华,刘光辉.亚低温联合颅内血肿微创清除术治疗对重症高血压脑出血患者神经功能及预后的影响[J].临床医学工程,2022,29(7):965-966.
[18] 路连海,张培,董秀芳,等.微创颅内血肿清除术联合亚低温治疗对高血压脑出血的临床效果观察[J].医药卫生,2022(5):37-40.
[19] 翟红军.亚低温结合颅内血肿微创清除术用于重症高血压脑出血的治疗效果观察[J].医学美学美容,2018,27(17):30.
[20] 张祥海,刘帮会,龚道恺,等.微创血肿清除术联合亚低温疗法治疗高血压脑出血的临床研究[J].长江大学学报(自科版),2006,3(1):226-228.
[21] GIL-GARCIA C A,FLORES-ALVAREZ E,CEBRIAN-GARCIA R,et al.Essential topics about the imaging diagnosis and treatment of hemorrhagic stroke:a comprehensive review of the 2022 AHA guidelines[J].Curr Probl Cardiol,2022,47(11):101328.
[22] 刘东晖,林清国,王文阳,等.亚低温在出血性脑卒中治疗中的作用研究进展[J].中国当代医药,2019,26(1):24-26,30.
[23] SHI H,SU Z,SU H,et al.Mild hypothermia improves brain injury in rats with intracerebral hemorrhage by inhibiting IRAK2/NF-κB signaling pathway[J].Brain Behav,2020:e01947.
[24] 王旭,王芳.局部亚低温联合行为护理干预对蛛网膜下腔出血患者康复进程的影响[J].现代医学,2020,48(4):540-543.
[25] IBAYASHI S,TAKANO K,OOBOSHI H,et al.Effect of selective brain hypothermia on regional cerebral blood flow and tissue metabolism using brain thermo-regulator in spontaneously hypertensive rats[J].Neurochem Res,2000,25(3):369-375.
[26] NILSEN J H,SCHANCHE T,KONDRATIEV T V,et al.Maintaining intravenous volume mitigates hypothermia-induced myocardial dysfunction and accumulation of intracellular Ca2+[J].Exp Physiol,2021,106(5):1196-1207.
[27] WU D,SHI J,ELMADHOUN O,et al.Dihydrocapsaicin(DHC) enhances the hypothermia-induced neuroprotection following ischemic stroke via PI3K/Akt regulation in rat[J].Brain Res,2017,1671:18-25.
[28] LIANG S,TI Y,LI X,et al.The protective role and mechanism of mild therapeutic hypothermia protection on brain cells[J].Neuropsychiatr Dis Treat,2023,19:1625-1631. |